Merit Medical Reports Q3 2026 Results, Raises Full-Year Guidance
Merit Medical reported 9% organic constant-currency revenue growth and raised its full-year 2026 guidance.
Story updates
08:11:16 PM UTC
SquawkNews
Merit Medical reported Q3 2026 non-GAAP EPS of $1.12, up 22% YoY, on 9% organic constant-currency revenue growth, and raised full-year 2026 revenue and non-GAAP EPS guidance.Material DetailsContext by AI AnalystThis reinforces a mid-cycle trend of steady growth and margin improvement following port…